Integration of biological knowledge and gene expression data for biomarker selection: FN1 as a potential predictor of radiation resistance in head and neck cancer

Cancer Biology and Therapy

Volumn 10, Issue 12, 2010, Pages 1252-1255

  Amundson, Sally A ^a   Smilenov, Lubomir B ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

Fibronectin; HNSCC; Integrin signaling; Network; Prognostic signatures; Radiation sensitivity

Indexed keywords

BIOLOGICAL MARKER; FIBRONECTIN; INTEGRIN RECEPTOR;

BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CANCER SURVIVAL; CELL FUNCTION; EXTRACELLULAR MATRIX; GENE EXPRESSION; HEAD AND NECK CANCER; METASTASIS; MICROARRAY ANALYSIS; NOTE; PROTEIN BINDING; RADIOSENSITIVITY; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; SURVIVAL TIME;

BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; FIBRONECTINS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEAD AND NECK NEOPLASMS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RADIATION TOLERANCE;

EID: 78650330414     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.10.12.13731     Document Type: Note

References (22)

1. vant't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415:530-6; DOI: 10.1038/415530a. (Pubitemid 34130608)
2. Haibe-Kains B, Desmedt C, Piette F, Buyse M, Cardoso F, Van't Veer L, et al. Comparison of prognostic gene expression signatures for breast cancer. BMC Genomics 2008; 9:394; DOI: 10.1186/1471-2164-9-394.
3. Ein-Dor L, Kela I, Getz G, Givol D, Domany E. Outcome signature genes in breast cancer: is there a unique set? Bioinformatics 2005; 21:171-8; DOI: 10.1093/bioinformatics/bth469. (Pubitemid 40202018)
4. Ein-Dor L, Zuk O, Domany E. Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proc Natl Acad Sci USA 2006; 103:5923-8; DOI: 10.1073/pnas.0601231103.
5. Koscielny S. Why most gene expression signatures of tumors have not been useful in the clinic. Sci Transl Med 2010; 2:14; DOI: 10.1126/scitranslmed. 3000313.
6. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003; 100:8418-23; DOI: 10.1073/pnas. 0932692100. (Pubitemid 36842560)
7. Haibe-Kains B, Desmedt C, Sotiriou C, Bontempi G. A comparative study of survival models for breast cancer prognostication based on microarray data: does a single gene beat them all? Bioinformatics 2008; 24:2200-8; DOI: 10.1093/bioinformatics/btn374.
8. Jerhammar F, Ceder R, Garvin S, Grénman R, Grafström RC, Roberg K. Fibronectin 1 is a potential biomarker for radioresistance in head and neck squamous cell carcinoma. Cancer Biol Ther 2010; 10:1244-51.
9. Potti A, Dressman HK, Bild A, Riedel RF, Chan G, Sayer R, et al. Genomic signatures to guide the use of chemotherapeutics. Nat Med 2006; 12:1294-300; DOI: 10.1038/nm1491. (Pubitemid 44706932)
10. Bonnefoi H, Potti A, Delorenzi M, Mauriac L, Campone M, Tubiana-Hulin M, et al. Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial. Lancet Oncol 2007; 8:1071-8; DOI: 10.1016/S1470-2045(07)70345-5. (Pubitemid 350182953)
11. Lee JK, Havaleshko DM, Cho H, Weinstein JN, Kaldjian EP, Karpovich J, et al. A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery. Proc Natl Acad Sci USA 2007; 104:13086-91; DOI: 10.1073/ pnas.0610292104.
12. Williams PD, Lee JK, Theodorescu D. Genomancy: predicting tumour response to cancer therapy based on the oracle of genetics. Curr Oncol 2009; 16:56-8.
13. Qin J, Vinogradova O, Plow EF. Integrin bidirectional signaling: a molecular view. PLoS Biol 2004; 2:169; DOI: 10.1371/journal.pbio.0020169. (Pubitemid 39234431)
14. Cordes N, Blaese MA, Meineke V, Van Beuningen D. Ionizing radiation induces upregulation of functional beta1-integrin in human lung tumour cell lines in vitro. Int J Radiat Biol 2002; 78:347-57; DOI: 10.1080/ 09553000110117340. (Pubitemid 34496887)
15. Cordes N, Hansmeier B, Beinke C, Meineke V, van Beuningen D. Irradiation differentially affects substratum-dependent survival, adhesion and invasion of glioblastoma cell lines. Br J Cancer 2003; 89:2122-32; DOI: 10.1038/sj.bjc. 6601429. (Pubitemid 38030913)
16. Sandfort V, Koch U, Cordes N. Cell adhesion-mediated radioresistance revisited. Int J Radiat Biol 2007; 83:727-32; DOI: 10.1080/09553000701694335. (Pubitemid 350219112)
17. Chiarugi P. From anchorage dependent proliferation to survival: lessons from redox signalling. IUBMB Life 2008; 60:301-7; DOI: 10.1002/iub.45.
18. Yao ES, Zhang H, Chen YY, Lee B, Chew K, Moore D, et al. Increased beta1 integrin is associated with decreased survival in invasive breast cancer. Cancer Res 2007; 67:659-64; DOI: 10.1158/0008-5472.CAN-06-2768. (Pubitemid 46192205)
19. Park CC, Zhang HJ, Yao ES, Park CJ, Bissell MJ. Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts. Cancer Res 2008; 68:4398-405; DOI: 10.1158/0008-5472.CAN-07-6390.
20. Pereira AL, Veras SS, Silveira EJ, Seabra FR, Pinto LP, Souza LB, et al. The role of matrix extracellular proteins and metalloproteinases in head and neck carcinomas: an updated review. Braz J Otorhinolaryngol 2005; 71:81-6; DOI: S0034-72992005000100014.
21. Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, et al. Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 2008; 14:518-27; DOI: 10.1038/nm1764. (Pubitemid 351655218)
22. Sund M, Kalluri R. Tumor stroma derived biomarkers in cancer. Cancer Metastasis Rev 2009; 28:177-83; DOI: 10.1007/s10555-008-9175-2.